You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 7, 2025

Drug Price Trends for NDC 49884-0161


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 49884-0161

Drug Name NDC Price/Unit ($) Unit Date
CALCITONIN-SALMON 200 UNIT SPR 49884-0161-11 13.98180 ML 2025-01-22
CALCITONIN-SALMON 200 UNIT SPR 49884-0161-11 12.75057 ML 2024-12-18
CALCITONIN-SALMON 200 UNIT SPR 49884-0161-11 12.63596 ML 2024-11-20
CALCITONIN-SALMON 200 UNIT SPR 49884-0161-11 11.76126 ML 2024-10-23
CALCITONIN-SALMON 200 UNIT SPR 49884-0161-11 10.53599 ML 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 49884-0161

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
CALCITONIN,SALMON 200UNT/ACCTUAT SOLN,NASAL,S Par Pharmaceutical, Inc. 49884-0161-11 3.7ML 21.11 5.70541 2021-02-23 - 2025-09-28 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 49884-161-11

Introduction

The National Drug Code (NDC) 49884-161-11 corresponds to Calcitonin Salmon Nasal Solution, a medication used for the treatment of postmenopausal osteoporosis. This article provides a comprehensive market analysis and price projections for this drug, considering various factors such as regulatory requirements, market trends, and global price comparisons.

Regulatory Overview

The NDC 49884-161-11 is listed in the FDA's National Drug Code Directory, which contains information on active and certified finished and unfinished drugs submitted by labelers. The NDC is a unique, three-segment number that identifies the labeler, product, and trade package size[1][5].

Market Context

Drug Classification and Usage

Calcitonin Salmon Nasal Solution is classified as a human prescription drug, indicated for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause. It is marketed by Par Pharmaceutical, Inc.[3].

Global Price Comparisons

Studies have shown that prescription drug prices in the United States are significantly higher than in many other countries. For instance, U.S. prices for brand-name originator drugs are 344% of those in comparison OECD countries, while prices for unbranded generic drugs are generally lower in the U.S. compared to other countries[2].

Market Trends

Pharmacy Market Outlook

The Vizient Pharmacy Market Outlook for 2024-2025 projects a stable overall drug price inflation rate of 0.00% for the period between January 1, 2025, and December 31, 2025. However, this outlook does not specifically address the prices of individual drugs like Calcitonin Salmon Nasal Solution[4].

Gene Therapy and Advanced Treatments

While the focus on gene therapy and other advanced treatments highlights the escalating costs of healthcare, it does not directly impact the pricing of established drugs like Calcitonin Salmon Nasal Solution. However, it underscores the broader trend of increasing healthcare costs and the need for sustainable financial models[4].

Price Projections

Current Pricing

As of the latest data, specific price projections for Calcitonin Salmon Nasal Solution (NDC 49884-161-11) are not readily available. However, given the general trend of stable or slightly increasing prices for prescription drugs, it is reasonable to expect that the price of this drug will remain relatively stable or increase marginally.

Comparative Pricing

In the context of global price comparisons, if Calcitonin Salmon Nasal Solution were to follow the trend of brand-name originator drugs, its price in the U.S. would likely remain significantly higher than in other OECD countries. However, since it is not a newly approved drug, its pricing is less likely to be as volatile as that of newer, more expensive therapies[2].

Factors Influencing Pricing

Regulatory Compliance

Drug establishments must update their drug listing data in June and December of each year to ensure compliance with FDA regulations. Any changes in the listing status or compliance issues could potentially affect the availability and pricing of the drug[1].

Market Demand and Competition

The demand for osteoporosis treatments and the presence of competing drugs can influence the pricing strategy. If there are alternative treatments gaining market share, the price of Calcitonin Salmon Nasal Solution might be adjusted to remain competitive.

Economic and Policy Factors

Economic conditions, healthcare policies, and reimbursement rates can also impact drug pricing. For example, changes in Medicare or Medicaid reimbursement policies could affect the market price of prescription drugs, including Calcitonin Salmon Nasal Solution.

Conclusion

The market analysis and price projections for Calcitonin Salmon Nasal Solution (NDC 49884-161-11) suggest a relatively stable pricing environment, influenced by broader trends in prescription drug pricing. While specific price projections are not available, the drug is likely to maintain its current pricing structure, with potential minor adjustments based on market demand, competition, and regulatory compliance.

Key Takeaways

  • Regulatory Compliance: The drug must comply with FDA regulations, including regular updates to the NDC Directory.
  • Global Price Comparisons: U.S. prices for brand-name drugs are generally higher than in other OECD countries.
  • Market Trends: Stable overall drug price inflation is projected for 2025, but specific drug prices can vary.
  • Pricing Factors: Market demand, competition, and economic policies can influence drug pricing.
  • Healthcare Costs: The broader trend of increasing healthcare costs underscores the need for sustainable financial models.

FAQs

Q: What is the NDC code for Calcitonin Salmon Nasal Solution?

A: The NDC code for Calcitonin Salmon Nasal Solution is 49884-161-11.

Q: What is the primary use of Calcitonin Salmon Nasal Solution?

A: Calcitonin Salmon Nasal Solution is used for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause.

Q: How do U.S. prices for prescription drugs compare to those in other countries?

A: U.S. prices for brand-name originator drugs are significantly higher than in many other OECD countries, while prices for unbranded generic drugs are generally lower in the U.S.[2].

Q: What are the key factors influencing the pricing of Calcitonin Salmon Nasal Solution?

A: Key factors include regulatory compliance, market demand, competition, and economic policies.

Q: Are there any specific price projections available for Calcitonin Salmon Nasal Solution for 2025?

A: As of the latest data, specific price projections for this drug are not readily available, but it is expected to remain relatively stable or increase marginally.

Sources

  1. FDA: National Drug Code Database Background Information.
  2. ASPE: International Prescription Drug Price Comparisons.
  3. DailyMed: Calcitonin Salmon spray, metered.
  4. Vizient Inc.: Pharmacy Market Outlook Summer 2024.
  5. FDA: National Drug Code Directory.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.